Patients
Physicians
Pharmaceutical Companies
Why Aureon?
Applications
Case Studies
 

Applications

Pre-Clinical Development Translational  Research Clinical Development    Drug Rescue
 Measure effect of target protein expression pre and post treatment Measure effect of target protein expression before and after treatment  Validation of molecular biomarkers  Retrospective analysis of patient cohort to identify biometric signatures associated with response
 Quantitate disease markers pre and post treatment Quantitate disease markers pre and post treatment   Retrospective analysis of responders to construct biometric profile (molecular, histological, clinical attributes).  Prospective identification of therapeutic responders for smaller, less costly, trials with higher response rates
Quantitate disease and target markers as a result of dosing and time course studies Identify correlations between disease markers expressed in human tissue compared to animal models Prospective identification of therapeutic responders for smaller, less costly, trials with higher response rates